Clinical Investigator
Joy Schleyer
Skyline Biosciences
Total Trials
1
As PI
0
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 11
Trial Status
Other1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
Leukoplakia, Oral
Studydirector
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Skyline Biosciences
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
6 similar investigators found
Giovanni Lodi, PhD, DMD
University of Milan
2 trials
Shared therapeutic areas:
Leukoplakia Oral
Similarity Score30%
Glenn Hanna, MD
Dana-Farber Cancer Institute
4 trials
Shared therapeutic areas:
Leukoplakia Oral
Similarity Score30%
Antoine Gessain, PhD
Institut Pasteur
1 trials
Shared therapeutic areas:
Leukoplakia Oral
Similarity Score30%
Chloé Bertolus, MD
APHP
1 trials
Shared therapeutic areas:
Leukoplakia Oral
Similarity Score30%
Jay O. Boyle, M.D.
Memorial Sloan Kettering Cancer Center
1 trials
Shared therapeutic areas:
Leukoplakia Oral
Similarity Score30%
Marta Sawczuk, MPH
Warszawski Uniwersytet Medyczny - Doktorant
1 trials
Shared therapeutic areas:
Leukoplakia Oral
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
Leukoplakia, Oral
All 1 trials loaded